The first nine companies to debut on the ASX in 2026 are all now trading in negative territory, down 26% on average from their issue prices.  

That is not bad luck.

Instead, it reflects a well-documented, repeating pattern in IPO markets, one that Australian retail investors tend to learn the hard way. 

What actually happened to the first nine ASX IPOs

The most instructive example is SkinKandy Ltd (ASX: SK1), Australia's largest specialty piercing and jewellery retailer. SkinKandy debuted in May after a ~$160 million IPO. 

The company listed with proper business credentials: more than 100 studios across Australia and New Zealand, a profitable track record, and ambitious international expansion plans.

The stock popped on day one, as most ASX IPOs do. Then it faded.

KTEK Aerosystems Ltd (ASX: KTK), the Israeli-founded Perth-headquartered defence composite manufacturer, tells a similar story.

KTK debuted on a strong business tailwind: supplying airframe components to defence contractors, including Elbit Systems. KTK's IPO came at a moment when defence spending was surging globally.

Again, a day-one pop, followed by a steady drift below the issue price.

Kaoko Metals Ltd (ASX: KAO), a copper explorer in Namibia with drill-ready projects, also joined the list of underwater debutants despite debuting into a strong copper price environment.

The mechanics of why IPOs so often disappoint after debut

The day-one pop is well documented. But it is consistently a poor guide to long-term returns.

According to updated long-run IPO statistics, the average newly listed company underperforms its peers by approximately 2.1% per year over the five years following its debut, regardless of how strongly it opens on day one.

The problem is that IPO pricing is set by investment banks whose job is to maximise the proceeds for the company being floated. Their job is not to find the price that is most attractive for incoming shareholders. 

That means IPOs are more likely to be priced at or above fair value than below it.

Furthermore, the lock-up periods that prevent insiders and pre-IPO investors from selling typically expire in the months following a listing. This then creates persistent selling pressure over the longer term.

The debut pop is not the same as a buying opportunity

The most common mistake retail investors make with IPOs is confusing the excitement of a debut with evidence that the business is worth buying at that price.

A stock rising 30% on day one tells you that demand exceeded supply at the issue price.

It tells you nothing about whether the issue price was fair relative to the company's intrinsic value.

In fact, a large day-one pop is often a signal that the investment bank priced the deal too cheaply. This is a gift to institutional investors who were allocated shares at the IPO price, not a gift to retail investors buying in the open market at 30% above that price.

The investors who did well from the 2026 ASX IPO class so far are the institutional investors and sophisticated pre-IPO holders who received allocations at the issue price, not retail investors who chased the opening pop.

What this means for investors considering July's pipeline

July is set to be the busiest month for ASX IPOs in 2026, with nine more companies scheduled to debut. These future IPOs include an AI-focused listed trust, a rare earths spin-off, and a large commercial construction float.

The lesson from the first nine is not to avoid IPOs entirely. But it is to apply the same analytical discipline to a new listing that you would apply to any other investment.

Ask whether the business model is strong, whether the price being asked is fair, and whether you are being offered a share of the upside that makes the risk worthwhile.

Most of the time, waiting three to six months for the post-IPO dust to settle produces a better entry point than chasing the debut excitement.

Foolish Takeaway for ASX IPOs

The first nine ASX IPOs of 2026 are all underwater, down 26% on average.

That is not a coincidence or a run of bad luck. But it does reflect the reality that IPOs are priced to serve sellers, not buyers.

Patient investors who wait for the post-debut hype to fade before assessing a new listing at a more rational price tend to do better over time than those who chase the debut pop.

The post The first nine ASX IPOs of 2026 are all trading in the red. Here is what that tells investors appeared first on The Motley Fool Australia.

The shares briefly traded higher, hitting $2.51 at one stage, up from the offer price of $2.20, but have since fallen to be changing hands for $2.19.

The analyst team at Morgans see this as an opportunity, saying the retailer has a strong position in a growing market segment and a long runway of potential store openings.

Before diving deeper into what the broker's analyst team thinks of the shares, let's check in on what the company's Chair, Trent Peterson, said about its prospects in the prospectus.

Bolstered by excellent management

Mr Peterson said the company is the leading specialist piercing retailer across Australia and New Zealand, and operates a "repeat-driven retail format" in which piercings are the core service rather than an ancillary one.

Mr Peterson added:

Founded by Mark Oliphant in Queensland in 2010, SkinKandy has grown from a single store into a network of 100 company-owned stores2 across Australia and New Zealand. Throughout this journey, the Company has invested significantly in its operating platform, including its people, systems and store design, to enable repeatable execution and agile expansion capabilities.

Mr Peterson said in 2023, the company brought in Dain Friis as Chief Executive Officer, with Mr Friis having worked in high-level executive roles, including as Chief Operating Officer of Lovisa Ltd (ASX: LOV).

In terms of the company's growth prospects, Mr Peterson said:

The Board believes SkinKandy operates in a large, attractive and growing market. The industry in ANZ remains highly fragmented, with over 1,000 independent salons, beauty operators and pharmacies offering piercing as an ancillary service, presenting a compelling opportunity for a scaled specialist operation with a consistent customer proposition and strong operational standards which are designed to allow SkinKandy to grow share profitably. There is opportunity for further market share gains and the Board expects a progressive consolidation in the market to occur over the long term.  

This ASX retail stock looks cheap

The Morgans team said they saw several growth levers ahead for the company, including acquisitions, 15-20 store openings per year, and the potential for international expansion.

They are forecasting the company's earnings per share to grow at a compound 33% from FY25 to FY28.

They added:

We see this as a compelling opportunity to invest in a high-quality retailer with a strong store rollout opportunity. We initiate coverage with a buy recommendation and a $2.90 price target.

This would be a 32.4% gain if achieved. SkinKandy is valued at $245.7 million.

The post This newly-listed ASX retail stock could deliver more than 30% upside Morgans says appeared first on The Motley Fool Australia.